Hematologic responses in patients treated with VRD
| . | Month 1 (evaluable n = 34) . | Month 3 (evaluable n = 27) . | Month 6 (evaluable n = 24) . | ITT (N = 34) . |
|---|---|---|---|---|
| CR | 1 (3) | 6 (22) | 11 (46) | 11 (32) |
| VGPR | 14 (41) | 16 (59) | 11 (46) | 17 (50) |
| PR | 9 (27) | 5 (18) | 2 (8) | 2 (7) |
| . | Month 1 (evaluable n = 34) . | Month 3 (evaluable n = 27) . | Month 6 (evaluable n = 24) . | ITT (N = 34) . |
|---|---|---|---|---|
| CR | 1 (3) | 6 (22) | 11 (46) | 11 (32) |
| VGPR | 14 (41) | 16 (59) | 11 (46) | 17 (50) |
| PR | 9 (27) | 5 (18) | 2 (8) | 2 (7) |
Values represent n (%) of patients.